Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants
Clinical trial NCT04971395 · COMPLETED
Trial details
- NCT number
- NCT04971395
- Sponsor
- Xentria, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2022-03-18
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.